Summit Financial, LLC Astrazeneca PLC Transaction History
Summit Financial, LLC
- $2.83 Billion
- Q4 2024
A detailed history of Summit Financial, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Summit Financial, LLC holds 9,642 shares of AZN stock, worth $670,793. This represents 0.02% of its overall portfolio holdings.
Number of Shares
9,642
Previous 9,840
2.01%
Holding current value
$670,793
Previous $766,000
17.62%
% of portfolio
0.02%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,381Shares Held
475MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.2 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.85 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.61 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.67 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.36 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $216B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...